Scientists Find Drug That May Fight Alzheimer's on Multiple Fronts
Summary
Scientists have discovered an experimental drug called KCL-286 that may help treat Alzheimer's disease by repairing brain cell DNA and reducing inflammation. Tests in mice show promise, and the drug has passed early human safety trials, but more funding is needed to start testing it in Alzheimer's patients.Key Facts
- KCL-286 is an oral drug developed by King's College London researchers.
- It helps fix DNA damage in brain cells and lowers inflammation linked to Alzheimer's.
- The drug activates a protein (RARβ) that starts DNA repair processes.
- KCL-286 also increases BRCA1 protein levels, important for repairing DNA.
- The drug improved brain immune and support cells in a mouse Alzheimer's model.
- It has finished Phase I safety trials in healthy humans.
- A small trial in Alzheimer's patients could begin soon if funding is found.
- Current treatments mostly target amyloid proteins, but KCL-286 uses a different approach by helping brain cells fix themselves.
Read the Full Article
This is a fact-based summary from The Actual News. Click below to read the complete story directly from the original source.
